Analysts Viewpoint
KYMR price target predicted to rise nearly 59 in 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s recent filing unveils that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s filing revealed that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s recent filing unveils that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s recent filing unveils that its Director BAKER BROS. ADVISORS LP acquired Company’s shares for reported $28.84 million
Kymera Therapeutics Inc’s recent filing unveils that its Director Ridloff Elena unloaded Company’s shares for reported $0.23 million on Jun